Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T20:43:28.280Z.
Calculation as of: 2026-10-06T20:43:28.280Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 9ec8996c3a848f33a2c42fb16e066100176f843ed6f4363e42c2f797510b2bab
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2017-12-29.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
EV/EBIT RATIO AVG TTM
N/A
EV/EBIT RATIO AVG 3Y
N/A
EV/EBIT RATIO AVG 5Y
N/A
EV/EBIT RATIO AVG 10Y
N/A
EV/EBIT RATIO AVG 15Y
N/A
EV/EBIT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$2.02B
EV/EBIT Ratio
12.59x
TTM Avg
22.52x
3Y Avg
26.44x
5Y Avg
26.44x
Market Cap
$2.02B
EV/EBIT Ratio
N/A
TTM Avg
41.80x
3Y Avg
41.80x
5Y Avg
41.80x
Market Cap
$2.05B
EV/EBIT Ratio
110.67x
TTM Avg
307.23x
3Y Avg
485.43x
5Y Avg
1367.82x
Market Cap
$1.98B
EV/EBIT Ratio
265.92x
TTM Avg
247.10x
3Y Avg
123.52x
5Y Avg
99.39x
Market Cap
$2.06B
EV/EBIT Ratio
N/A
TTM Avg
4584.86x
3Y Avg
4584.86x
5Y Avg
4584.86x
Market Cap
$1.97B
EV/EBIT Ratio
34.61x
TTM Avg
44.12x
3Y Avg
112.76x
5Y Avg
112.76x
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | $2.02B | N/A | N/A | N/A | N/A |
| Aurinia Pharmaceuticals Inc. (AUPH)vs › | $2.02B | 12.59x | 22.52x | 26.44x | 26.44x |
| BioCryst Pharmaceuticals, Inc. (BCRX)vs › | $2.02B | N/A | 41.80x | 41.80x | 41.80x |
| Progyny, Inc. (PGNY)vs › | $2.03B | 16.98x | 21.63x | 33.37x | 79.37x |
| Vericel Corporation (VCEL)vs › | $2.05B | 110.67x | 307.23x | 485.43x | 1367.82x |
| Fortrea Holdings Inc. (FTRE)vs › | $1.98B | 265.92x | 247.10x | 123.52x | 99.39x |
| Celldex Therapeutics, Inc. (CLDX)vs › | $2.06B | N/A | 4584.86x | 4584.86x | 4584.86x |
| Viridian Therapeutics, Inc. (VRDN)vs › | $2.06B | N/A | N/A | N/A | N/A |
| Inspire Medical Systems, Inc. (INSP)vs › | $1.97B | 34.61x | 44.12x | 112.76x | 112.76x |
| Alvotech (ALVO)vs › | $2.08B | 71.54x | 53.16x | 49.42x | 49.42x |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBIT RATIO |
|---|---|
| 2017-12-29 | 98.92x |
| 2017-12-28 | 102.22x |
| 2017-12-27 | 102.51x |
| 2017-12-26 | 100.09x |
| 2017-12-22 | 103.87x |
| 2017-12-21 | 102.99x |
| 2017-12-20 | 101.02x |
| 2017-12-19 | 103.11x |
| 2017-12-18 | 107.08x |
| 2017-12-15 | 101.24x |
| 2017-12-14 | 98.57x |
| 2017-12-13 | 97.62x |
| 2017-12-12 | 103.18x |
| 2017-12-11 | 100.51x |
| 2017-12-08 | 102.89x |
| 2017-12-07 | 105.43x |
| 2017-12-06 | 100.00x |
| 2017-12-05 | 103.37x |
| 2017-12-04 | 109.15x |
| 2017-12-01 | 106.67x |
| 2017-11-30 | 108.96x |
| 2017-11-29 | 108.13x |
| 2017-11-28 | 109.15x |
| 2017-11-27 | 110.26x |
| 2017-11-24 | 110.77x |
| 2017-11-22 | 108.35x |
| 2017-11-21 | 110.67x |
| 2017-11-20 | 113.50x |
| 2017-11-17 | 110.96x |
| 2017-11-16 | 108.58x |
| 2017-11-15 | 112.74x |
| 2017-11-14 | 114.71x |
| 2017-11-13 | 118.14x |
| 2017-11-10 | 111.08x |
| 2017-11-09 | 102.25x |
| 2017-11-08 | 102.06x |
| 2017-11-07 | 98.73x |
| 2017-11-06 | 97.68x |
| 2017-11-03 | 97.68x |
| 2017-11-02 | 88.06x |
| 2017-11-01 | 82.63x |
| 2017-10-31 | 81.51x |
| 2017-10-30 | 78.12x |
| 2017-10-27 | 71.00x |
| 2017-10-26 | 68.24x |
| 2017-10-25 | 71.41x |
| 2017-10-24 | 74.27x |
| 2017-10-23 | 67.57x |
| 2017-10-20 | 67.38x |
| 2017-10-19 | 67.95x |
| 2017-10-18 | 69.44x |
| 2017-10-17 | 72.40x |
| 2017-10-16 | 72.65x |
| 2017-10-13 | 72.84x |
| 2017-10-12 | 75.61x |
| 2017-10-11 | 78.40x |
| 2017-10-10 | 76.62x |
| 2017-10-09 | 75.38x |
| 2017-10-06 | 73.99x |
| 2017-10-05 | 77.48x |
| 2017-10-04 | 78.81x |
| 2017-10-03 | 82.28x |
| 2017-10-02 | 82.91x |
